PYPD
Price
$4.93
Change
-$0.00 (-0.00%)
Updated
May 2, 6:59 PM EST
4 days until earnings call
VRAX
Price
$0.62
Change
-$0.05 (-7.46%)
Updated
May 3, 6:59 PM EST
Ad is loading...

PYPD vs VRAX ᐉ Comparison: Which is Better to Invest?

Header iconPYPD vs VRAX Comparison
Open Charts PYPD vs VRAXBanner chart's image
PolyPid
Price$4.93
Change-$0.00 (-0.00%)
Volume$1.4K
CapitalizationN/A
Virax Biolabs Group
Price$0.62
Change-$0.05 (-7.46%)
Volume$22.94K
CapitalizationN/A
View a ticker or compare two or three
PYPD vs VRAX Comparison Chart

Loading...

VRAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PYPD vs. VRAX commentary
May 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYPD is a Hold and VRAX is a Hold.

COMPARISON
Comparison
May 05, 2024
Stock price -- (PYPD: $4.94 vs. VRAX: $0.61)
Brand notoriety: PYPD and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PYPD: 33% vs. VRAX: 98%
Market capitalization -- PYPD: $23.7M vs. VRAX: $1.45M
PYPD [@Biotechnology] is valued at $23.7M. VRAX’s [@Biotechnology] market capitalization is $1.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PYPD’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • PYPD’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, VRAX is a better buy in the long-term than PYPD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VRAX’s TA Score shows that 4 TA indicator(s) are bullish.

  • VRAX’s TA Score: 4 bullish, 4 bearish.

Price Growth

PYPD (@Biotechnology) experienced а +3.95% price change this week, while VRAX (@Biotechnology) price change was -11.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -3.94%, and the average quarterly price growth was +1240.85%.

Reported Earning Dates

PYPD is expected to report earnings on Aug 07, 2024.

VRAX is expected to report earnings on Aug 12, 2022.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PYPD with price predictions.
OPEN
A.I.dvisor published
a Summary for VRAX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PYPD($23.7M) has a higher market cap than VRAX($1.45M). PYPD YTD gains are higher at: 30.000 vs. VRAX (-57.952).
PYPDVRAXPYPD / VRAX
Capitalization23.7M1.45M1,634%
EBITDAN/AN/A-
Gain YTD30.000-57.952-52%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
VRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
VRAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGREX8.560.09
+1.06%
Invesco Global Real Estate R5
DFALX27.530.25
+0.92%
DFA Large Cap International I
EQNTX21.020.18
+0.86%
MFS Equity Income R3
BPAIX31.500.22
+0.70%
Boston Partners All Cap Value Instl
LIOTX10.34N/A
N/A
Issachar I

PYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYPD has been loosely correlated with VTYX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PYPD jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+2.92%
VTYX - PYPD
37%
Loosely correlated
-1.22%
LBPH - PYPD
34%
Loosely correlated
-6.29%
AMLX - PYPD
29%
Poorly correlated
+1.50%
INM - PYPD
28%
Poorly correlated
-8.30%
VRAX - PYPD
28%
Poorly correlated
+0.64%
More

VRAX and

Correlation & Price change

A.I.dvisor tells us that VRAX and NTRB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VRAX and NTRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
+0.64%
NTRB - VRAX
31%
Poorly correlated
-4.38%
PTGX - VRAX
30%
Poorly correlated
+2.15%
PYPD - VRAX
28%
Poorly correlated
+2.92%
CMRX - VRAX
24%
Poorly correlated
+0.28%
VTGN - VRAX
23%
Poorly correlated
+2.04%
More